{"id":3415,"date":"2023-03-20T12:26:59","date_gmt":"2023-03-20T12:26:59","guid":{"rendered":"https:\/\/planescomplementariossalud.es\/?p=3415"},"modified":"2023-11-23T15:03:46","modified_gmt":"2023-11-23T15:03:46","slug":"screentech-proyectos-cribado-farmacos","status":"publish","type":"post","link":"https:\/\/planescomplementariossalud.es\/gl\/screentech-proyectos-cribado-farmacos\/","title":{"rendered":"El Plan Complementario de Biotecnolog\u00eda aplicada a la Salud impulsar\u00e1 proyectos de cribado de alto rendimiento para acelerar el descubrimiento de nuevos f\u00e1rmacos"},"content":{"rendered":"\n<p><strong>El pr\u00f3ximo 27 de marzo, se abrir\u00e1 la llamada a expresiones de inter\u00e9s \u201cSCREENTECH&#8221; dentro del Plan Complementario de Biotecnolog\u00eda en Catalu\u00f1a. Esta iniciativa priorizar\u00e1 el desarrollo de nuevos proyectos en la plataforma de cribado de f\u00e1rmacos y an\u00e1lisis de interacciones f\u00e1rmaco-diana del IRB Barcelona. <\/strong><\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"510\" height=\"340\" src=\"https:\/\/planescomplementariossalud.es\/wp-content\/uploads\/2023\/03\/drug-screening-platform_IRB.jpg\" alt=\"\" class=\"wp-image-3404\" srcset=\"https:\/\/planescomplementariossalud.es\/wp-content\/uploads\/2023\/03\/drug-screening-platform_IRB.jpg 510w, https:\/\/planescomplementariossalud.es\/wp-content\/uploads\/2023\/03\/drug-screening-platform_IRB-300x200.jpg 300w\" sizes=\"(max-width: 510px) 100vw, 510px\" \/><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-constrained wp-container-core-column-is-layout-0e4c74ee wp-block-column-is-layout-constrained\" style=\"flex-basis:25%\"><\/div>\n<\/div>\n\n\n\n<p>El objetivo de la L\u00ednea de Actuaci\u00f3n 3 (LA3) del Plan Complementario de Biotecnolog\u00eda aplicada a la Salud es desarrollar un sistema integrado de cribado de alto rendimiento a trav\u00e9s de la \u201c<strong><a href=\"https:\/\/www.irbbarcelona.org\/en\/research\/drug-screening-platform\" target=\"_blank\" rel=\"noreferrer noopener\">plataforma de cribado<em> <\/em>de f\u00e1rmacos y de an\u00e1lisis de interacciones f\u00e1rmaco-diana<\/a><\/strong>\u201d del IRB Barcelona. Dicho sistema pretende dar apoyo a proyectos de investigaci\u00f3n que permitan identificar y optimizar nuevos compuestos susceptibles de ser utilizados en medicina general y de precisi\u00f3n, as\u00ed como el reposicionamiento de f\u00e1rmacos para nuevas aplicaciones.\u00a0<br>\u00a0<br>A nivel auton\u00f3mico, Catalu\u00f1a contar\u00e1 con el nodo Instituto de Investigaci\u00f3n Biom\u00e9dica (IRB Barcelona) para realizar los cribados de alto rendimiento y estudios de interacciones f\u00e1rmaco-diana. Para ello, se ha previsto el fortalecimiento de su plataforma de cribado de f\u00e1rmacos. De esta forma, se ejecutar\u00e1n una serie de actuaciones para incrementar su capacidad de procesamiento y de an\u00e1lisis de datos. Adem\u00e1s, se la dotar\u00e1 de tecnolog\u00edas punteras en monitorizaci\u00f3n biol\u00f3gica y se contratar\u00e1 personal altamente cualificado. Gracias a este fortalecimiento, esta plataforma promover\u00e1 servicios traslacionales \u00fanicos en un marco asequible, colaborativo y abierto a toda la comunidad cient\u00edfica.\u00a0<br>\u00a0<br>En este contexto, el pr\u00f3ximo 27 de marzo, se abrir\u00e1 el programa SCREENTECH, llamamiento para recibir expresiones de inter\u00e9s (EdI) para la realizaci\u00f3n cribados de alto rendimiento utilizando esta plataforma.\u00a0\u00a0<br>\u00a0<br>Esta llamada est\u00e1 cofinanciada por el Plan de  Recuperaci\u00f3n, Transformaci\u00f3n y Resiliencia (PRTR C17.I1), la Uni\u00f3n Europea NextGenerationEU y la Comunidad Aut\u00f3noma de Catalu\u00f1a. Se dirige a agentes catalanes, p\u00fablicos o privados, sin \u00e1nimo de lucro, que realicen actividades de investigaci\u00f3n cient\u00edfica y t\u00e9cnica enfocadas a la medicina personalizada.\u00a0<br>\u00a0<br>Se destinar\u00e1 un presupuesto total de <strong>452.000 \u20ac<\/strong>, con una <strong>dotaci\u00f3n m\u00e1xima de 56.500 \u20ac<\/strong> <strong>por EdI<\/strong> seleccionada, hasta agotar dicho presupuesto.\u00a0\u00a0<br>\u00a0<br>El plazo de presentaci\u00f3n de las EdI ser\u00e1 del 27 de marzo al 2 de mayo de 2023 a las 23:59 (hora peninsular espa\u00f1ola).\u00a0\u00a0<\/p>\n\n\n\n<p>M\u00e1s detalles <a href=\"https:\/\/planescomplementariossalud.es\/wp-content\/uploads\/2023\/03\/Llamada-SCREENTECH-vDEF-1.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">aqu\u00ed<\/a>. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>El pr\u00f3ximo 27 de marzo, se abrir\u00e1 la llamada a expresiones de inter\u00e9s \u201cSCREENTECH&#8221; dentro del Plan Complementario de Biotecnolog\u00eda en Catalu\u00f1a. Esta iniciativa priorizar\u00e1 el desarrollo de nuevos proyectos en la plataforma de cribado de f\u00e1rmacos y an\u00e1lisis de interacciones f\u00e1rmaco-diana del IRB Barcelona. El objetivo de la L\u00ednea de Actuaci\u00f3n 3 (LA3) del &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/planescomplementariossalud.es\/gl\/screentech-proyectos-cribado-farmacos\/\"> <span class=\"screen-reader-text\">El Plan Complementario de Biotecnolog\u00eda aplicada a la Salud impulsar\u00e1 proyectos de cribado de alto rendimiento para acelerar el descubrimiento de nuevos f\u00e1rmacos<\/span> Ler m\u00e1is &raquo;<\/a><\/p>\n","protected":false},"author":3,"featured_media":3407,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[78],"tags":[197,88],"class_list":["post-3415","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualidad-gl","tag-catalunya-gl","tag-cribado-de-farmacos-gl"],"_links":{"self":[{"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/posts\/3415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/comments?post=3415"}],"version-history":[{"count":7,"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/posts\/3415\/revisions"}],"predecessor-version":[{"id":4577,"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/posts\/3415\/revisions\/4577"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/media\/3407"}],"wp:attachment":[{"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/media?parent=3415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/categories?post=3415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/planescomplementariossalud.es\/gl\/wp-json\/wp\/v2\/tags?post=3415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}